Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir.
Prian
G W
GW
Department of Surgery, Good Samaritan Regional Medical Center, Phoenix, Arizona.
Koep
L J
LJ
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous; D016031:Liver Transplantation / Q000009:adverse effects; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies
D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D016853:Muromonab-CD3; C045781:cytomegalovirus-specific hyperimmune globulin; D015774:Ganciclovir; D000212:Acyclovir